Citigroup »

Cyclerion Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Cyclerion Therapeutics (CYCN) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Cyclerion Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cyclerion Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclerion Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $136 89 1.54

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Cyclerion Therapeutics

Siren
Geode Capital Management
Vanguard Group
Citadel Advisors
BlackRock
Vanguard Capital Management
XTX Topco
Kovack Advisors
Vanguard Fiduciary Trust
FMR
UBS Group
Tower Research Capital
Group One Trading
Advisor Group Holdings
MAI Wealth Advisors

View all funds holding Cyclerion Therapeutics